Molecular Diagnostics Market is projected to exceed US$ 20 Billion by 2024
by Rajat Gupta Renub Research is a Market Research and Consulting
Molecular diagnostics is termed as to the
detection of genomic variants, with the aim to facilitate physicians in the
detection, prognosis, diagnosis, sub-classification and further monitoring
response to the given therapy. Molecular diagnostics is the outcome of
productive relationships between genomics knowledge, laboratory medicine and
the use of improved technology in the field of molecular genetics. All these
factors help in the better recognition and fine categorization of the genetic
basis of inherited diseases which in turn, is essential for the accurate
specification of disease diagnosis. Global Molecular Diagnostics Market is projected to exceed US$
20 Billion by
the year 2024.
Polymerase Chain Reaction (PCR) and
Next-Generation Sequencing (NGS)
Over the last few decades,
several molecular assays have been developed using a variety of technologies.
Molecular diagnostics by using Polymerase Chain Reaction (PCR) is one of the
leading molecular diagnostics technologies, which is being used for the rapid
diagnosis of various diseases. For instance: diagnosis of pulmonary
tuberculosis using Polymerase Chain Reaction (PCR) is demonstrating a high
yield even in patients with sputum smear-negative pulmonary tuberculosis and is
now being endorsed for routine use by WHO. High-end molecular diagnostic
techniques such as next-generation sequencing (NGS) offer valuable insights
into the mechanisms of disease while genomic biomarkers provide physician not
only to evaluate the disease predilection but also to implement accurate
diagnostic techniques and to individualize medicinal modalities.
Molecular Diagnostics for Infectious Disease
Over the last several years, the
expansion and application of molecular diagnostic techniques has spurred a
revolution in the field of disease diagnosis and monitoring, especially for
infectious diseases. Microbial phenotypic characteristics, such as
bacteriophage, protein and chromatographic profiles, as well as susceptibility
testing and biotyping, are used wide openly in today’s everyday laboratories
for identification and differentiation. Nucleic acid techniques, such as
various methods for generating restriction fragment length polymorphisms,
plasmid profiling, and the polymerase chain reaction (PCR), are making
increasing incursion into clinical laboratories. A PCR-based system helps to
detect the etiology of the disease straight from the clinical samples without
the need for culture and have been significantly useful in the rapid detection
of un-culturable or fastidious microbes. In addition; sequence analysis of
amplified microbial DNA allows for better characterization and identification
of the pathogen.
Click here for Diagnostics Market Research
Further, molecular diagnostics
have also paved the roads for the microbiologists who now searched for go for
more rapid and efficient means of microbial identification. The identification
and differentiation of microbes have basically relied on the microbial growth
variables and their morphology. Advancement in the molecular diagnostics has
opened new possibilities for microbial identification and characterization.
Diagnostics Market is exploding very rapidly in the past few years as it has
proven readily versatile for use in the clinical laboratory and promise to be
exceptionally useful in the diagnosis, therapy, and epidemiologic
investigations of various diseases and their control; it is believed that the
molecular diagnostics market will keep flourishing in the coming years. Also,
rapid detection and tests accuracy are believed to drive demand for molecular
diagnostic tests for infectious disease.
Created on Feb 12th 2019 00:35. Viewed 187 times.